Global Automated Cell Culture Market Analysis 2021-2031

The global automated cell culture market is anticipated to grow with a CAGR of 8.7% over the forecast period, i.e., 2022 - 2031. Factors such as the surge in research and development activities in the field of medical science, along with the low error and high efficiency associated with the use of the automated production process are anticipated to drive the growth of the market in the coming years. Additionally, factors such as the growing chronic and infectious diseases globally, and the growing need for advanced drugs are also expected to add to the market growth in the coming years. The market is estimated to garner a revenue of near to USD 26410 Million by the end of 2031, up from a revenue of about USD 11500 Million in the year 2021.

The global automated cell culture market is segmented into numerous segments, which include segmentation by product, application, end-user, and by region. By application, the market is segmented into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, gene therapy, stem cell research, diagnostics, toxicity testing, and others. By the end of 2031, the biopharmaceutical production segment is anticipated to garner the largest revenue of around USD 5870 Million. Further, in the year 2021, the segment generated a revenue of about USD 2530 Million.

Regionally, the global automated cell culture market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. By the end of 2031, the market in North America is projected to garner the largest revenue of close to USD 11540 Million by the end of 2031. Additionally, in the year 2021, the market in the region generated a revenue of near to USD 5100 Million.

Some of the prominent industry leaders in the global automated cell culture market that are included in our report are Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Becton, Dickinson and Company, Cell Culture Company, LLC, Lonza Group, and others.